Literature DB >> 24092929

Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions.

Kosuke Yamahara1, Shinji Kume, Daisuke Koya, Yuki Tanaka, Yoshikata Morita, Masami Chin-Kanasaki, Hisazumi Araki, Keiji Isshiki, Shin-ichi Araki, Masakazu Haneda, Taiji Matsusaka, Atsunori Kashiwagi, Hiroshi Maegawa, Takashi Uzu.   

Abstract

Obesity is an independent risk factor for renal dysfunction in patients with CKDs, including diabetic nephropathy, but the mechanism underlying this connection remains unclear. Autophagy is an intracellular degradation system that maintains intracellular homeostasis by removing damaged proteins and organelles, and autophagy insufficiency is associated with the pathogenesis of obesity-related diseases. We therefore examined the role of autophagy in obesity-mediated exacerbation of proteinuria-induced proximal tubular epithelial cell damage in mice and in human renal biopsy specimens. In nonobese mice, overt proteinuria, induced by intraperitoneal free fatty acid-albumin overload, led to mild tubular damage and apoptosis, and activated autophagy in proximal tubules reabsorbing urinary albumin. In contrast, diet-induced obesity suppressed proteinuria-induced autophagy and exacerbated proteinuria-induced tubular cell damage. Proximal tubule-specific autophagy-deficient mice, resulting from an Atg5 gene deletion, subjected to intraperitoneal free fatty acid-albumin overload developed severe proteinuria-induced tubular damage, suggesting that proteinuria-induced autophagy is renoprotective. Mammalian target of rapamycin (mTOR), a potent suppressor of autophagy, was activated in proximal tubules of obese mice, and treatment with an mTOR inhibitor ameliorated obesity-mediated autophagy insufficiency. Furthermore, both mTOR hyperactivation and autophagy suppression were observed in tubular cells of specimens obtained from obese patients with proteinuria. Thus, in addition to enhancing the understanding of obesity-related cell vulnerability in the kidneys, these results suggest that restoring the renoprotective action of autophagy in proximal tubules may improve renal outcomes in obese patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24092929      PMCID: PMC3810079          DOI: 10.1681/ASN.2012111080

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  51 in total

1.  Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance.

Authors:  Y Li; X C Li; X X Zheng; A D Wells; L A Turka; T B Strom
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

Review 2.  The role of proteinuria in the progression of chronic renal failure.

Authors:  C Burton; K P Harris
Journal:  Am J Kidney Dis       Date:  1996-06       Impact factor: 8.860

3.  Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis.

Authors:  R A Risdon; J C Sloper; H E De Wardener
Journal:  Lancet       Date:  1968-08-17       Impact factor: 79.321

4.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

5.  Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage.

Authors:  Atsuko Kamijo; Kenjiro Kimura; Takeshi Sugaya; Masaya Yamanouchi; Hiromi Hase; Tomoyo Kaneko; Yasunobu Hirata; Atsuo Goto; Toshiro Fujita; Masao Omata
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

Review 6.  Tubulointerstitial changes as a major determinant in the progression of renal damage.

Authors:  K A Nath
Journal:  Am J Kidney Dis       Date:  1992-07       Impact factor: 8.860

7.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

8.  Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Authors:  J C Peterson; S Adler; J M Burkart; T Greene; L A Hebert; L G Hunsicker; A J King; S Klahr; S G Massry; J L Seifter
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

9.  Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.

Authors:  Attila Garami; Fried J T Zwartkruis; Takahiro Nobukuni; Manel Joaquin; Marta Roccio; Hugo Stocker; Sara C Kozma; Ernst Hafen; Johannes L Bos; George Thomas
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

10.  In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker.

Authors:  Noboru Mizushima; Akitsugu Yamamoto; Makoto Matsui; Tamotsu Yoshimori; Yoshinori Ohsumi
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

View more
  92 in total

Review 1.  Role of autophagy in the regulation of adipose tissue biology.

Authors:  Montserrat Romero; Antonio Zorzano
Journal:  Cell Cycle       Date:  2019-06-03       Impact factor: 4.534

2.  Proximal tubules forget "self-eating" when they meet Western meals.

Authors:  Ken Inoki
Journal:  J Am Soc Nephrol       Date:  2013-10-03       Impact factor: 10.121

Review 3.  Proteostasis in endoplasmic reticulum--new mechanisms in kidney disease.

Authors:  Reiko Inagi; Yu Ishimoto; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2014-04-22       Impact factor: 28.314

Review 4.  Low-protein diet for diabetic nephropathy.

Authors:  Toshiki Otoda; Keizo Kanasaki; Daisuke Koya
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 5.  Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management.

Authors:  Yingmei Zhang; Adam T Whaley-Connell; James R Sowers; Jun Ren
Journal:  Pharmacol Ther       Date:  2018-06-22       Impact factor: 12.310

6.  Janus Kinase 2 Regulates Transcription Factor EB Expression and Autophagy Completion in Glomerular Podocytes.

Authors:  Tamadher A Alghamdi; Syamantak Majumder; Karina Thieme; Sri N Batchu; Kathryn E White; Youan Liu; Angela S Brijmohan; Bridgit B Bowskill; Suzanne L Advani; Minna Woo; Andrew Advani
Journal:  J Am Soc Nephrol       Date:  2017-04-19       Impact factor: 10.121

7.  Hydrogen sulfide mitigates hyperglycemic remodeling via liver kinase B1-adenosine monophosphate-activated protein kinase signaling.

Authors:  Sourav Kundu; Sathnur Pushpakumar; Syed J Khundmiri; Utpal Sen
Journal:  Biochim Biophys Acta       Date:  2014-08-13

8.  Obesity, Acute Kidney Injury, and Mortality in Critical Illness.

Authors:  John Danziger; Ken P Chen; Joon Lee; Mengling Feng; Roger G Mark; Leo Anthony Celi; Kenneth J Mukamal
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

9.  Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES.

Authors:  Tatsuya Tominaga; Rajesh K Dutta; Darukeshwara Joladarashi; Toshio Doi; Janardan K Reddy; Yashpal S Kanwar
Journal:  J Biol Chem       Date:  2015-11-17       Impact factor: 5.157

10.  Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.

Authors:  Zhibo Gai; Ting Gui; Christian Hiller; Gerd A Kullak-Ublick
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.